Herbs yield results with Aids patients
by Chris Jenkins
July 12 2005 at 12:30PM
This
article was originally published on page 6 of The Mercury on July
12, 2005
Gaunt and motionless, a young woman in her 30s
lies in her warm bed in the Holy Cross Hospice at eMoyeni and stares
up at the face of the person standing next to her lightly massaging
her face with a herbal cream.
She is one of hundreds of HIV and Aids victims
- many of them nearing death - that Empangeni ethnobotanist and
Zululand University Research Fellow Anne Hutchings has tended to
over the years in far-flung areas of northern KwaZulu-Natal around
Empangeni and Mtubatuba, relieving the effects of their terrible
skin conditions and easing painful joints.
In many cases she has been able to give her patients
a new lease of life, thanks to the use of a range of herbal medication,
most importantly Sutherlandia, which has shown incredible results
on patients staring at a slow and ghastly death.
| 'Sutherlandia may in some cases be a significant
factor in delaying the need for ARV therapy' |
At the weekend Hutchings paid yet another visit to eMoyeni, a place
of hope where dedicated nursing staff, headed by Sister Priscilla
Dlamini, a Catholic nun and nursing sister, care for patients in
the late stages of the incurable syndrome.
'Sutherlandia may in some cases be a significant
factor in delaying the need for ARV therapy'
Dlamini's work at eMoyeni and Hutchings's remarkable success with
herbal remedies have not gone unnoticed.
Both have been the focus of media attention locally
and overseas, and on Friday a BBC Science team investigating herbal
medicine in South Africa, including the widely used indigenous plant
Sutherlandia frutescens (cancer bush), were at the hospice where
they gained insight into efforts being made to ease the agonising
suffering of patients with full-blown Aids.
British broadcasting journalists and researchers
were in Zululand to document the success stories of patients who
have shown remarkable improvement. Hutchings's expertise in the
field of herbal medicine and work with Aids sufferers has led many
of them to believe their lives have been prolonged.
Hutchings and Dlamini have been able to share their
knowledge on the use of these medications and nursing procedures
with small groups of local traditional healers. This has been met
with an enthusiastic response.
The work with Sutherlandia and the creams was initiated
by invitation at Ngwelezana Hospital's HIV Support Clinic five years
ago and since then informed and consenting patients have been treated.
Numbers have grown dramatically and this has been attributed to
word of mouth from people who have seen the difference the treatment
has made to other patients they know.
Among those who have been treated in the HIV Support
Clinic have been those suffering from chronic conditions such as
diabetes, asthma and high blood pressure who appear to take the
Sutherlandia well with no apparent adverse side-effects when it
is taken with their chronic medication.
Sutherlandia is an effective immune-booster long
used for a multitude of complaints. Its well documented properties
have been and are still being widely researched around the world.
Preparations from the herb Warburgia have been
extremely helpful in pain and infection control, and African ginger
is very popular for headache and insomnia. Frequent significant
and often sustainable weight gains attributed to the Sutherlandia
have been recorded, Hutchings says.
One of her first patients to have been treated
at Ngwelezana clinic, Nonhlanhla Zungu, was diagnosed HIV-positive
11 years ago and in 1998 she went down with spinal tuberculosis.
The prognosis for patients with such TB and Aids
is poor, but after a month on Sutherlandia she reported she was
able to do housework. Recent blood screening showed her to be well
above the limit at which patients are now being given anti-retrovials
(ARVs) by the state system.
"This has also been observed recently in other
patients and indicates that the Sutherlandia may in some cases be
a significant factor in delaying the need for ARV therapy,"
Hutchings said.
She continues with her work, but little funding
has been available and Hutchings is working largely on a voluntary
basis.
|